Liu S, Benito-Martin A, Vatter FAPelissie, Hanif SZ, Liu C, Bhardwaj P, Sethupathy P, Farghli AR, Piloco P, Paik P et al..  2023.  Breast adipose tissue-derived extracellular vesicles from obese women alter tumor cell metabolism.. EMBO Rep. 24(12):e57339.

Choo Z-N, Behr JM, Deshpande A, Hadi K, Yao X, Tian H, Takai K, Zakusilo G, Rosiene J, Paula ADa Cruz et al..  2023.  Most large structural variants in cancer genomes can be detected without long reads.. Nat Genet. 55(12):2139-2148.

Bhardwaj P, Iyengar NM, Zahid H, Carter KM, Byun DJun, Choi MHo, Sun Q, Savenkov O, Louka C, Liu C et al..  2023.  Obesity promotes breast epithelium DNA damage in women carrying a germline mutation in BRCA1 or BRCA2.. Sci Transl Med. 15(684):eade1857.

Morton LM, Sampson JN, Armstrong GT, Chen T-H, Hudson MM, Karlins E, Dagnall CL, Li SAlfred, Wilson CL, Srivastava DKumar et al..  2017.  Genome-Wide Association Study to Identify Susceptibility Loci That Modify Radiation-Related Risk for Breast Cancer After Childhood Cancer.. J Natl Cancer Inst. 109(11)

Pitman JA, McGinty GB, Soman RR, Drotman MB, Reichman MB, Arleo EKagan.  2017.  Screening Mammography for Women in Their 40s: The Potential Impact of the American Cancer Society and U.S. Preventive Services Task Force Breast Cancer Screening Recommendations.. AJR Am J Roentgenol. 209(3):697-702.

Halberg N, Sengelaub CA, Navrazhina K, Molina H, Uryu K, Tavazoie SF.  2016.  PITPNC1 Recruits RAB1B to the Golgi Network to Drive Malignant Secretion.. Cancer Cell. 29(3):339-353.

Fang J, Xiao L, Joo K-I, Liu Y, Zhang C, Liu S, Conti PS, Li Z, Wang P.  2016.  A potent immunotoxin targeting fibroblast activation protein for treatment of breast cancer in mice.. Int J Cancer. 138(4):1013-23.

Sengelaub CA, Navrazhina K, Ross JB, Halberg N, Tavazoie SF.  2016.  PTPRN2 and PLCβ1 promote metastatic breast cancer cell migration through PI(4,5)P2-dependent actin remodeling.. EMBO J. 35(1):62-76.

Ross JB, Huh D, Noble LB, Tavazoie SF.  2015.  Identification of molecular determinants of primary and metastatic tumour re-initiation in breast cancer.. Nat Cell Biol. 17(5):651-64.

Furlow PW, Zhang S, T Soong D, Halberg N, Goodarzi H, Mangrum C, Y Wu G, Elemento O, Tavazoie SF.  2015.  Mechanosensitive pannexin-1 channels mediate microvascular metastatic cell survival.. Nat Cell Biol. 17(7):943-52.

Walsh LA, Roy DM, Reyngold M, Giri D, Snyder A, Turcan S, Badwe CR, Lyman J, Bromberg J, King TA et al..  2015.  RECK controls breast cancer metastasis by modulating a convergent, STAT3-dependent neoangiogenic switch.. Oncogene. 34(17):2189-203.

Sibaud V, Niec RE, Schindler K, Busam KJ, Roché H, Modi S, Delord JPierre, Lacouture ME.  2014.  Ado-trastuzumab emtansine-associated telangiectasias in metastatic breast cancer: a case series.. Breast Cancer Res Treat. 146(2):451-6.

Lanier ST, Wang ED, Chen JJ, Arora BP, Katz SM, Gelfand MA, Khan SU, Dagum AB, Bui DT.  2010.  The effect of acellular dermal matrix use on complication rates in tissue expander/implant breast reconstruction.. Ann Plast Surg. 64(5):674-8.

Shelly W, Draper MW, Krishnan V, Wong M, Jaffe RB.  2008.  Selective estrogen receptor modulators: an update on recent clinical findings.. Obstet Gynecol Surv. 63(3):163-81.

Draper MW.  2006.  An update on raloxifene.. Int J Gynecol Cancer. 16 Suppl 2:502-3.

Tobin SW, Douville K, Benbow U, Brinckerhoff CE, Memoli VA, Arrick BA.  2002.  Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.. Oncogene. 21(1):108-18.

Wijayaratne AL, Nagel SC, Paige LA, Christensen DJ, Norris JD, Fowlkes DM, McDonnell DP.  1999.  Comparative analyses of mechanistic differences among antiestrogens.. Endocrinology. 140(12):5828-40.